Abstract:Most patients with late-onset neurodegenerative diseases such as Alzheimer's and Parkinson's have a complex aetiology resulting from numerous genetic risk variants of small effects located across the genome, environmental factors, and the interaction between genes and environment. Over the last decade, genome-wide association studies (GWAS) and post-GWAS analyses have shed light on the polygenic architecture of these diseases, enabling polygenic risk scores (PRS) to estimate an individual's relative genetic liability for presenting with the disease. PRS can screen and stratify individuals based on their genetic risk, potentially years or even decades before the onset of clinical symptoms. An emerging body of evidence from various research studies suggests that genetic susceptibility to late-onset neurodegenerative diseases might impact early life outcomes, including cognitive function, brain structure and function, and behaviour. This article summarises recent findings exploring the potential impact of genetic susceptibility to neurodegenerative diseases on early life outcomes. A better understanding of the impact of genetic susceptibility to neurodegenerative diseases early in life could be valuable in disease screening, detection, and prevention and in informing treatment strategies before significant neural damage has occurred. However, ongoing studies have limitations. Overall, our review found several studies focused on APOE haplotypes and Alzheimer's risk, but a limited number of studies leveraging polygenic risk scores or focused on genetic susceptibility to other late-onset conditions.

What problem does this paper attempt to address?

This paper attempts to explore the impact of genetic susceptibility on late - onset neurodegenerative diseases (such as Alzheimer's disease and Parkinson's disease) in the early life stage (including cognitive function, brain structure and function, behavior, etc.). Specifically, the paper summarizes the research achievements in recent years on the association between genetic factors and neurodegenerative - disease - related phenotypes (such as cognitive function, brain structure and function, behavior, etc.) at different ages, and discusses the limitations of current research and the possible directions for future research. The paper emphasizes that understanding the impact of genetic susceptibility on these diseases in the early life stage is of great significance for disease screening, detection, prevention and the formulation of treatment strategies, especially before significant nerve damage occurs. In addition, the paper also explores the application of polygenic risk scores (PRS) in identifying high - risk individuals. These individuals may show a high genetic risk years or decades before the appearance of clinical symptoms. By implementing PRS early, valuable information can be provided for the diagnosis and personalized treatment strategies of neurodegenerative diseases.

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure